Treating Ebola in eastern DRC

Rojek, Amanda M, Jacob, Shevin ORCID: https://orcid.org/0000-0003-2425-9394 and Dunning, Jake (2020) 'Treating Ebola in eastern DRC'. Lancet Infectious Diseases, Vol 20, Issue 3, pp. 284-285.

Text Rojek et al. Correspondence Fedson_Treating Ebola.docx - Submitted Version Download (19kB)

Abstract

Since the onset of the west Africa Ebola Virus Disease (EVD) outbreak, there has been remarkable progress in efforts to provide patients with improved supportive care and access to experimental treatments. It is reasonable to explore the potential therapeutic value of both pathogen-directed antiviral therapies and host-directed therapies (e.g., monoclonal antibody cocktails). Given unacceptably high mortality rates among EVD patients, treatments demonstrated to be safe and efficacious in clinical trials would likely be welcomed by clinicians and affected communities.

Item Type:	Article
Additional Information:	Correspondence
Subjects:	WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries WC Communicable Diseases > Virus Diseases > Viral Hemorrhagic Fevers. Other Virus Diseases > WC 534 Viral hemorrhagic fevers
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1016/S1473-3099(20)30046-3
Depositing User:	Marie Hatton
Date Deposited:	21 May 2020 12:03
Last Modified:	20 Sep 2020 01:02
URI:	https://archive.lstmed.ac.uk/id/eprint/14480

Statistics

View details

Actions (login required)

Edit Item